Meyka Pro banner
Uscom Limited

Uscom Limited Fundamental Analysis (ASX: UCM.AX)

UCM.AX●ASX
HealthcareMedical - Devices
$0.01
$0.001(9.09%)
Australian Market opens in 52h 29m

Uscom Limited Fundamental Analysis (ASX: UCM.AX)

Uscom Limited (ASX: UCM.AX) shows weak financial fundamentals with a PE ratio of -1.56, profit margin of -1.06%, and ROE of -17.89%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.12
Current Ratio1.66

Areas of Concern

ROE-17.89%
Operating Margin-2.88%
Cash Position0.06%
We analyze UCM.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2301.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2301.0/100

We analyze UCM.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

UCM.AX struggles to generate sufficient returns from assets.

ROA > 10%
-2.81%

Valuation Score

Excellent

UCM.AX trades at attractive valuation levels.

PE < 25
-1.56
PEG Ratio < 2
-0.12

Growth Score

Weak

UCM.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

UCM.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.12
Current Ratio > 1
1.66

Profitability Score

Weak

UCM.AX struggles to sustain strong margins.

ROE > 15%
-1788.57%
Net Margin ≥ 15%
-1.06%
Positive Free Cash Flow
No

Key Financial Metrics

Is UCM.AX Expensive or Cheap?

P/E Ratio

UCM.AX trades at -1.56 times earnings. This suggests potential undervaluation.

-1.56

PEG Ratio

When adjusting for growth, UCM.AX's PEG of -0.12 indicates potential undervaluation.

-0.12

Price to Book

The market values Uscom Limited at 17.08 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

17.08

EV/EBITDA

Enterprise value stands at -1.15 times EBITDA. This is generally considered low.

-1.15

How Well Does UCM.AX Make Money?

Net Profit Margin

For every $100 in sales, Uscom Limited keeps $-1.06 as profit after all expenses.

-1.06%

Operating Margin

Core operations generate -2.88 in profit for every $100 in revenue, before interest and taxes.

-2.88%

ROE

Management delivers $-17.89 in profit for every $100 of shareholder equity.

-17.89%

ROA

Uscom Limited generates $-2.81 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.81%

Following the Money - Real Cash Generation

Operating Cash Flow

Uscom Limited generates limited operating cash flow of $-2.81M, signaling weaker underlying cash strength.

$-2.81M

Free Cash Flow

Uscom Limited generates weak or negative free cash flow of $-2.82M, restricting financial flexibility.

$-2.82M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

UCM.AX converts -90.29% of its market value into free cash.

-90.29%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.56

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.12

vs 25 benchmark

P/B Ratio

Price to book value ratio

17.08

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.56

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.12

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.66

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-17.89

vs 25 benchmark

ROA

Return on assets percentage

-2.81

vs 25 benchmark

ROCE

Return on capital employed

-19.24

vs 25 benchmark

How UCM.AX Stacks Against Its Sector Peers

MetricUCM.AX ValueSector AveragePerformance
P/E Ratio-1.5631.14 Better (Cheaper)
ROE-1788.57%554.00% Weak
Net Margin-105.85%5163.00% Weak
Debt/Equity0.120.01 Weak (High Leverage)
Current Ratio1.665.75 Neutral
ROA-280.53%-245.00% (disorted) Weak

UCM.AX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Uscom Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ